SCHEMBL1745252

SCHEMBL1745252

OCc1ccc(Oc2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.80
TSHR P16473 2/20 0.52
TTR P02766 1/20 0.50
FYN P06241 1/20 0.49
MKNK1 Q9BUB5 1/20 0.48
MKNK2 Q9HBH9 1/20 0.48
MMP12 P39900 1/20 0.47
MMP13 P45452 1/20 0.47
FFAR1 O14842 1/20 0.47
GSTP1 P09211 2/20 0.47
PPARG P37231 2/20 0.46
PPARA Q07869 2/20 0.46
SRD5A2 P31213 1/20 0.46
S1PR1 P21453 1/20 0.46
S1PR3 Q99500 1/20 0.46
ABCC4 O15439 1/20 0.45
LMNA P02545 1/20 0.45
GAA P10253 1/20 0.45
PTGS1 P23219 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21993468 1.00 LTA4H (0.80) LTA4HTSHRTTRFYNMKNK1
SCHEMBL510065 0.89 LTA4H (1.00) LTA4HTSHRTTRFYNFFAR1
SCHEMBL1744936 0.89 LTA4H (1.00) LTA4HTSHRTTRFYNFFAR1
SCHEMBL28009007 0.87 LTA4H (0.95) LTA4HTSHRTTRFYNFFAR1
SCHEMBL28009008 0.87 LTA4H (0.95) LTA4HTSHRTTRFYNFFAR1
SCHEMBL70274 0.87 TSHR (0.68) LTA4HTSHRFYNMKNK1MKNK2
Biphenyl SCHEMBL27280595 0.87 TSHR (0.68) LTA4HTSHRFYNMKNK1MKNK2
SCHEMBL11274656 0.87 TSHR (0.68) LTA4HTSHRFYNMKNK1MKNK2
SCHEMBL14173672 0.86 LTA4H (0.70) LTA4HTSHRTTRFYNMMP12
SCHEMBL5342317 0.84 LTA4H (0.81) LTA4HTSHRTTRFFAR1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR LTA4H 1978/4885TSHR 128/4885TTR 4688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.